Use App
  • Trending
  • News
  • Earnings
DIADIA0.10%
SPYSPY0.37%
QQQQQQ1.38%
Trending
Top trending tickerRKLBRKLB12.39%
NBISNBIS12.38%
ASTSASTS17.69%
OKLOOKLO9.78%
MRVLMRVL8.59%
SNDKSNDK11.09%
ATAIATAI33.58%
UNHUNH3.33%
ORCLORCL4.63%
UAMYUAMY12.33%
Top trending tickerRKLBRKLB12.39%
NBISNBIS12.38%
ASTSASTS17.69%
OKLOOKLO9.78%
MRVLMRVL8.59%
SNDKSNDK11.09%
ATAIATAI33.58%
UNHUNH3.33%
ORCLORCL4.63%
UAMYUAMY12.33%

Feed

News

Sentiment

Earnings

Fundamentals

Info

homeSymbolATNM
Exchange: NYSEMkt·Updated 12:13 PM EDT
ATNM logo

ATNMActinium Pharmaceuticals Inc

$0.8921
$0.0278
(3.02%)
Today
Reported EarningsJul 28
Mkt Cap$28.86M
Vol28,318.00

Fundamentals

Mkt Cap
$28.86M
Volume
-
52W High
$1.89
52W Low
$0.88
PE Ratio
-1.22
Avg. Volume
151,128.22
EPS (Annual)
-$1.09
P/B
12.53
Rev/Employee
$3,600.00
Earnings
Jul 28

Advertisement|Remove ads.

Latest ATNM News

View
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer Research Annual Meeting
PR Newswire
News Placeholder
SLS Vs ATNM: Which Cancer Stock Has Bigger Upside Ahead Of Fresh Data Reveal?
Stocktwits
News Placeholder
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting
PR Newswire
News Placeholder
Loading...
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.

TrendingNews
CommunityProfile